Foley raises an interesting point about radiologists being responsible for the decision to biopsy patients undergoing MRI for a suspicion of prostate cancer [1]. Indeed, a key difference between the Likert system recommended in UK guidelines [2,3] and the PI-RADS system initially developed by the ESUR, is the ability to incorporate clinical information into the radiologists final report [4, 5].